MDXL — Medixall Cashflow Statement
0.000.00%
Last trade - 00:00- $0.02m
- $0.58m
- $0.31m
Annual cashflow statement for Medixall, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.42 | -5.93 | -6.2 | -6.83 | -4.56 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.643 | 2.29 | 1.18 | 2.32 | 1.75 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.432 | -0.486 | 0.331 | 0.877 | 1.18 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -2.34 | -4.13 | -4.69 | -3.56 | -1.23 |
| Capital Expenditures | -0.016 | -0.092 | -0.013 | -0.001 | 0 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Cash from Investing Activities | -0.016 | -0.092 | -0.013 | -0.001 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.6 | 4.42 | 4.12 | 3.5 | 1.24 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.245 | 0.2 | -0.582 | -0.06 | 0.007 |